The clinical use of blood and blood products is appropriate, and strategies are used to reduce the risks associated with transfusion. (NSQHS Standards, Hospital guide 2017).
Overarching PBM/transfusion-related guidelines, policies and procedures are found in the clinical governance section (7.1).
In this section are resources to assist health services address the actions in this criterion, which are:
- 7.4 optimising and conserving patent’s own blood - information can be found in the section marked
- 7.5 documenting
- 7.6 prescribing and administering blood and blood products
- 7.7 and 7.8 reporting adverse events.
The examples of charts, checklists and forms relating to the administration of blood products are used to promote complete transfusion documentation. The resources are designed to assist health services to support processes for prescribing and clinical use of blood and blood products.
- a comprehensive form developed by Austin Health. It is an example of a form used for blood and blood product prescription and administration, consent documentation and adverse reaction reporting as well as providing guidance on blood administration safety, and the pre-transfusion checking requirements.
Prescribing and administering blood and blood products 7.6
The Australian and New Zealand Society of Blood Transfusion (ANZSBT) and the Royal Australian College of Physicians (RACP) have developed a . This is useful guidance for clinical transfusion practice.
Prophylactic use of Rh D immunoglobulin for Rh D negative women: Rh D immunoglobulin administered to pregnant Rh D negative women can help prevent haemolytic disease of the fetus and newborn. To promote best practice and the provision of relevant information Blood Matters has developed the infographic
Reporting and adverse events 7.7 and 7.8
(7.5, 7.7 and 7.8) - developed at RMH for reporting transfusion reactions to the Transfusion Laboratory and includes the order for subsequent blood testing. This form is now only used when the EMR is not available.
(7.6) - the blood component compatibility report used at St Vincent’s Health, contains details of the compatibility of the blood component (the form is blank), and on the reverse side it has the blood checking requirements and a summary of possible adverse reactions. This is an example of the form that is sent with the unit of blood, blood product.
Reviewed 11 May 2022